Evidence map›Paper›PMID 29287984›Full record

ReviewMicrobes and infection

Alternative strategies for vaccination to brucellosis.

David W Pascual, Xinghong Yang, Hongbin Wang, Zakia Goodwin, Carol Hoffman, Beata Clapp

Open access · greenAbstract readReview
In one paragraph

Review in Microbes and infection. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cell insight · 2024
    Review
  5. Review
  6. Evaluation of the immunization of camels withOpen veterinary journal · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Uncovering the Hidden Credentials ofMicrobiology and molecular biology reviews : MMBR · 2021
    Review
  13. When the Going Gets Rough: The Significance ofFrontiers in microbiology · 2021
    Review
  14. [Editorial] COVID‑19: Post‑lockdown guidelines.International journal of molecular medicine · 2020
    Article
  15. Proteomics ofMicroorganisms · 2020
    Article
  16. Review
  17. VceC Mediated IRE1 Pathway and Inhibited CHOP-induced Apoptosis to SupportInternational journal of molecular sciences · 2019
    Article
  18. Zoonoses under our noses.Microbes and infection
    Review
  19. Microbes and Infection turns 20.Microbes and infection
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David W PascualDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA. Electronic address: pascuald@ufl.edu.
Xinghong YangDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.
Hongbin WangDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.
Zakia GoodwinDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.
Carol HoffmanDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.
Beata ClappDepartment of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, 32611, USA.
University of Florida · US

Funding

Mucosal Vaccines for BrucellosisR01AI123244 · NIAID · UNIVERSITY OF FLORIDA · PI PASCUAL, DAVID W · 2016 to 2020
$2.0M
Naso-oropharyngeal Brucella Infections and Mucosal Immune ProtectionR01AI125516 · NIAID · UNIVERSITY OF FLORIDA · PI PASCUAL, DAVID W · 2017 to 2021
$1.9M
NIAID NIH HHS R01 AI123244NIAID NIH HHS R01 AI125516
6 · The paper itself

Abstract

Brucellosis remains burdensome for livestock and humans worldwide. Better vaccines for protection are needed to reduce disease incidence. Immunity to brucellosis and barriers to protection are discussed. The benefits and limitations of conventional and experimental brucellosis vaccines are outlined, and novel vaccination strategies needed to ultimately protect against brucellosis are introduced.

Indexed as

Administration, MucosalAnimalsBrucella VaccineBrucellosisHumansImmunity, CellularVaccinationBrucella VaccineBacteriaMucosal immunityVaccine

Identifiers

PMID29287984
PMCPMC6019614
OpenAlexW2775972683

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.